Phase I study for assessment of safety of gene therapy with GX-12 in combination with HAART for the HIV-1 infected patients
Latest Information Update: 10 Nov 2021
At a glance
- Drugs GX 12 (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Genexine
- 22 Jun 2013 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently' (last verified May 2008).
- 11 May 2008 The expected completion date for this trial is now 1 Dec 2009 according to ClinicalTrials.gov.
- 28 Aug 2007 New trial record.